Published Apr 11, 2024 As advances in technology make the once science fiction idea of “de-extinction” closer to becoming a reality, what does it actually mean for a de-extinction company to be a real business?
That’s what I sat down to talk to Colossal Biosciences CEO and founder Ben Lamm about. Colossal has made headlines pursuing the de-extinction of the woolly mammoth, the Tasmanian tiger, and the dodo. The company’s raised more than $225 million to date, and its backers include USIT, Bold Capital Partners, Breyer Capital, Bob Nelsen, At One Ventures, and more.
“De-extinction and species preservation are connected,” said Lamm. “Sometimes people want to separate out species preservation, conservation, and I say, no, they’re all one thing.”
Colossal’s conservation efforts are wide-ranging. For example, the startup is currently working with the University of Alaska and University of Stockholm on one of the largest-ever studies focused on radiocarbon dating mammoths. Likewise, Colossal last year joined the BioRescue group working to save the northern white rhino from extinction. And, there’s the Victorian grassland earless dragon—a miniscule Australian lizard believed to be extinct in 1969. The lizard was recently re-discovered in the wild, and Colossal’s set up a breeding and release colony with the Melbourne Zoo devoted to the fetching little reptile.
|